// App-Quantinova.ai

[SAT0448] : INTERLEUKIN-1 DUAL VARIABLEDOMAIN IMMUNOGLOBULIN REDUCES MULTIPLE IMFLAMMATORY MARKERS IN KNEE OSTEOARTHRITIS PATIENTS

Researchers

Presenter

  • S. X. Wang

Principal Investigators

  • J. K. Medema

  • M. P. Kosloski

  • W. Liu

  • M. J. Saltarelli

  • M. Karsdal

Medical Centers

  • N/A

Locations

  • N/A

Companies

  • AbbVie Inc.

  • Nordic Bioscience A/

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Systemic inflammation

  • Knee osteoarthritis

  • Osteoarthritis

  • Peritoneal colorectal carcinomatosis

Biomarkers

  • C reactive protein

  • High sensitivity C-reactive protein

  • Interleukin 1

  • Vascular endothelial growth factor A

Drug/Treatment

  • Interleukin

  • ABT-981

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved